A detailed history of Israel Englander (Millennium Management LLC) transactions in Sol Gel Technologies Ltd. stock. As of the latest transaction made, Millennium Management LLC holds 12,301 shares of SLGL stock, worth $7,380. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,301
Previous 20,400 39.7%
Holding current value
$7,380
Previous $19,000 47.37%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$0.66 - $1.05 $5,345 - $8,503
-8,099 Reduced 39.7%
12,301 $10,000
Q1 2024

May 15, 2024

BUY
$0.95 - $1.5 $7,374 - $11,644
7,763 Added 61.43%
20,400 $19,000
Q4 2023

Feb 14, 2024

BUY
$0.92 - $1.6 $11,626 - $20,219
12,637 New
12,637 $13,000
Q2 2020

Aug 14, 2020

SELL
$6.15 - $9.4 $69,212 - $105,787
-11,254 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$5.88 - $15.75 $66,173 - $177,250
11,254 New
11,254 $79,000

Others Institutions Holding SLGL

About Sol-Gel Technologies Ltd.


  • Ticker SLGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,129,500
  • Market Cap $13.9M
  • Description
  • Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...
More about SLGL
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.